Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Leuk Lymphoma. 2013 Nov 1;55(6):1345–1349. doi: 10.3109/10428194.2013.840780

Table II.

Risk factors for HDMTX-mediated renal toxicity and delayed MTX elimination.

Grade 2-4 renal toxicity Delayed MTX elimination
Yes (%) No (%) p-value Yes (%) No (%) p-value
Age* 60.8 51.3 <0.0001 57.6 50 <0.0001
Sex 0.0069^ <0.0001^
Male 78.3 58 73.7 52.4
Female 21.7 42 26.3 47.6
Baseline CrCl (mL/min) 0.0001# <0.0001§
30-59 41.3 9 18.7 7
60-89 28.3 21.1 29.8 19.3
>90 30.4 69.9 51.5 73.7
MTX dose (g/m2) 0.0671§ 0.1077^
1-2 13 7.1 2.3 5
>2-3 6.5 11.5 12.3 5.7
>3-4 69.6 54.7 45 54
>4-6 2.2 11.5 1.2 8.8
>6 8.7 15.3 39.2 26.5
PPI use 50 42.5 0.3237^ 53.8 39.3 0.0011^

Key:

^

chi-square test,

two sample T test,

#

Wilcoxon two sample test,

§

row mean score test,

*

age values in mean years